Showing 1 - 20 results of 54 for search 'Ørntoft, T', query time: 0.05s
Refine Results
-
1
-
2
Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer by Ørntoft Torben, Jensen Klaus, Wiuf Carsten, Zieger Karsten, Dyrskjøt Lars
Published 2009-05-01
Article -
3
-
4
-
5
-
6
-
7
Short-Term Results of Operative Treatment of Primary Ileocecal Crohn’s Disease: Retrospective, Comparative Analysis between Early (Luminal) and Complicated Disease by Nicolas Avellaneda, Tora Haug, Mai-Britt Worm Ørntoft, Sanne Harsløf, Lars Peter Skovgaard Larsen, Anders Tøttrup
Published 2023-04-01
Article -
8
-
9
Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma <it>in situ </it>in the urinary bladder by Ørntoft Torben F, Borre Michael, Wiuf Carsten, Thykjaer Thomas, Christensen Ole F, Herbsleb Malene, Dyrskjøt Lars
Published 2008-01-01
Article -
10
-
11
Effect of SNP haplotypes associated with colorectal cancer risk on outcome by Walther, A, Sieber, O, Domingo, E, Jaeger, E, Johnstone, E, Orntoft, T, Aaltonen, L, Kerr, D, Tomlinson, I
Published 2008Journal article -
12
-
13
-
14
Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells by Ørntoft Torben F, Hein Anne-Mette K, Wiuf Carsten, Thykjaer Thomas, Birkenkamp-Demtroder Karin, Herbsleb Malene, Dyrskjøt Lars
Published 2008-07-01
Article -
15
-
16
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression by Oleksiewicz Martin B, Ørntoft Torben F, Borre Michael, Fristrup Niels, Bartels Annette, Egerod Frederikke, Brünner Nils, Dyrskjøt Lars
Published 2009-10-01
Article -
17
Keratin23 (KRT23) knockdown decreases proliferation and affects the DNA damage response of colon cancer cells. by Karin Birkenkamp-Demtröder, Stephan A Hahn, Francisco Mansilla, Kasper Thorsen, Abdelouahid Maghnouj, Rikke Christensen, Bodil Øster, Torben Falck Ørntoft
Published 2013-01-01
Article -
18
Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer by Tine Maj Storebjerg, Siri H. Strand, Søren Høyer, Anne-Sofie Lynnerup, Michael Borre, Torben F. Ørntoft, Karina D. Sørensen
Published 2018-08-01
Article -
19
The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial. by Jacob Fredsøe, Jan Koetsenruyter, Peter Vedsted, Pia Kirkegaard, Michael Væth, Adrian Edwards, Torben F Ørntoft, Karina D Sørensen, Flemming Bro
Published 2020-02-01
Article -
20